Latest News 12.20.2024 U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer 12.19.2024 Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts ...
Pfizer's latest funding round is Other Investors. Who are the investors of Pfizer? Investors of Pfizer include Pfizer Venture Investments. Looking for a leg up on competitive, customer and technology insights? CB Insights puts confidence and clarity into your most strategic decisions. See how. Joi...
Get all the latest Pfizer vaccine news from The Jerusalem Post.Israel has embarked on a mass coronavirus vaccination campaign largely centered on the vaccine developed by Pfizer and BioNTech, the company’s German technology partner.About PfizerPfizer (traded as PFE on the New York stock exchange)...
Product Updates Product NDC and Vial Presentation Change... Product Updates Frequently Asked Questions Have a question? Your answer may be only a click away. Get started> Request Certificate of Compliance Get started> Find the Latest Supply Information on Our Products ...
Product Updates Frequently Asked Questions Have a question? Your answer may be only a click away. Get started> Request Certificate of Compliance Get started> Find the Latest Supply Information on Our Products Download availability report By checking this box, I also agree that Pfizer or companies ...
Pankhania says British authorities need to keep good records "because we also want to follow up [with] all the people that we immunize, and also survey a good representative group of people who have been immunized to look out for any unusual or unexpected side effects....
Meet the executive leadership team, our senior-most leadership and decision-making management body who focus on major financial, strategic, and operational decisions for the entire company. Pfizer wire Stay up to date on the latest news and alerts through the Pfizer Wire Sign up...
Global Blood Therapeutics MORE ON THIS TOPIC Pipeline JPM25 Day Two: Roche, Amgen, Merck, Lilly and Biogen January 15, 2025 · 4 min read · Tristan Manalac Gene therapy Regenxbio Jumps on Potential $800M Rare Disease Deal With Nippon Shinyaku ...
Source: Pfizer Inc. View this news release online at: http://www.businesswire.com/news/home/20230809028227/enTwitter LinkedIn Facebook Email Print FDA Approvals Best Places to Work Pfizer LATEST Earnings Pfizer Eyes Deals up to $15B, With ‘Fruitful’ C...
Sign up for the latest Pfizer Wire news alerts Receive real-time updates on Pfizer’s news delivered directly to your inbox. Our Pipeline: Potential Breakthroughs in the Making We're elevating our breakthroughs in a bold new way. Check out our new visualized product pipeline. Co...